WESTFIELD CAPITAL MANAGEMENT CO LP - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 217 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.3%.

Quarter-by-quarter ownership
WESTFIELD CAPITAL MANAGEMENT CO LP ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q4 2022$21,005,449
-60.3%
479,467
-40.3%
0.16%
-61.5%
Q3 2022$52,952,000
-24.3%
803,643
-42.0%
0.42%
-23.6%
Q2 2022$69,947,000
-6.7%
1,384,810
+18.0%
0.55%
+14.8%
Q1 2022$74,958,000
-36.3%
1,173,421
+6.8%
0.48%
-31.3%
Q4 2021$117,681,000
-5.8%
1,098,691
-9.6%
0.70%
-7.3%
Q3 2021$124,950,000
+20.4%
1,215,353
+3.0%
0.75%
+21.2%
Q2 2021$103,803,000
-5.4%
1,180,119
+4.6%
0.62%
-8.8%
Q1 2021$109,723,000
+12.7%
1,128,487
+30.0%
0.68%
+18.0%
Q4 2020$97,354,000
-1.0%
868,067
-18.2%
0.58%
-9.3%
Q3 2020$98,336,000
+19.8%
1,060,798
+0.8%
0.64%
+12.9%
Q2 2020$82,070,000
+37.0%
1,052,183
+2.7%
0.56%
+6.8%
Q1 2020$59,919,000
-2.9%
1,024,607
+33.0%
0.53%
+20.0%
Q4 2019$61,736,000
-0.8%
770,636
-9.0%
0.44%
-11.6%
Q3 2019$62,226,000
+7.7%
846,959
+38.3%
0.50%
+14.5%
Q2 2019$57,766,000
+54.5%
612,380
+31.1%
0.44%
+52.6%
Q1 2019$37,387,000
+19.0%
467,041
-19.9%
0.28%
+6.3%
Q4 2018$31,420,000
-21.0%
582,826
+14.4%
0.27%
-3.9%
Q3 2018$39,762,000
+194.1%
509,380
+139.2%
0.28%
+176.2%
Q2 2018$13,520,000212,9800.10%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 781,539$49,925,0007.34%
CADIAN CAPITAL MANAGEMENT, LP 1,921,347$122,736,0006.13%
Casdin Capital, LLC 1,550,000$99,014,0004.44%
DAFNA Capital Management LLC 246,280$15,732,0004.10%
Nextech Invest Ltd. 188,228$12,024,0003.43%
Eagle Health Investments LP 170,551$10,895,0002.68%
Integral Health Asset Management, LLC 153,000$9,774,0002.54%
Boxer Capital, LLC 507,374$32,411,0001.67%
Rock Springs Capital Management LP 947,715$60,540,0001.52%
EFG Asset Management (North America) Corp. 136,691$8,730,0001.31%
View complete list of BLUEPRINT MEDICINES CORP shareholders